Phase II Trial of Allovectin-7® for Head and Neck Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Study Completion Date

June 30, 2002

Conditions
Head and Neck CancerSquamous Cell Carcinoma of the Oral Cavity or OropharynxHead and Neck NeoplasmsCarcinoma of the Head and Neck
Interventions
GENETIC

Allovectin-7®

Trial Locations (10)

19104

University of Pennsylvania, Philadelphia

33612

H. Lee Moffitt Cancer Center & Research Institute, Tampa

35233

University of Alabama, Birmingham, Birmingham

44106

Case Western Reserve University, Cleveland

45267

University Cincinnati Medical Center, Cincinnati

48109

University of Michigan Medical Center, Ann Arbor

48202

Henry Ford Health System, Detroit

60637

University of Chicago, Chicago

70112

Louisiana State University, New Orleans

72205

University of Arkansas for Medical Sciences, Little Rock

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Vical

INDUSTRY